Viral load of human papillomavirus and risk of CIN3 or cervical cancer

Lancet

Volumn 360, Issue 9328, 2002, Pages 228-229

  Lorincz, Attila T ^a   Castle, Philip E ^b   Sherman, Mark E ^b   Scott, David R ^c   Glass, Andrew G ^c   Wacholder, Sholom ^b   Rush, Brenda B ^c   Gravitt, Patti E ^d   Schussler, John E ^e   Schiffman, Mark ^b  

^a Digene Corporation   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c KAISER PERMANENTE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; CYTODIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LAVAGE; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS LOAD; WART VIRUS;

EID: 0037143017     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)09463-1     Document Type: Article

References (5)

1. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: A nested case-control study
2. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia
3. HPV DNA testing in cervical cancer screening: Results from women in a high-risk province of Costa Rica
4. Natural history of cervical intraepithelial neoplasia: A critical review
5. Use of human papillomavirus DNA testing to compare equivocal cervical cytologic interpretations in the United States, Scandinavia, and the United Kingdom